Hints and tips:
Related Special Reports
...It has also worked on drug development for US pharma company Johnson & Johnson, Danish biotech group Genmab and British biotech Iksuda therapeutics....
...Pointing to increases in AstraZeneca’s research and development budget under Soriot, the successful launch of many blockbuster drugs and the expansion of the business into rare diseases, vaccines and immunology...
...Todd Rosenbluth, head of research at VettaFi, a consultancy, also believed the growth of model portfolios was a positive development....
...In the past year, Novo Nordisk has become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s most valuable pharma company, on the back of high demand...
...Others soon followed, such as PAVE, the Global X US Infrastructure Development ETF, and ROBO, the Global Robotics and Automation Index ETF. “A good ticker can go a long way in attracting investors....
...Concentration “is as high as it has been, certainly for the past three decades, potentially even longer”, said Dimitris Melas, head of index research and product development at MSCI....
...High demand for weight-loss drugs has helped Novo Nordisk become Europe’s largest company by market capitalisation, while Eli Lilly overtook Johnson & Johnson as the world’s largest pharmaceutical company...
...Spravato, a nasal spray based on a molecule from the psychedelic drug ketamine used to treat depression, already ranks as Johnson & Johnson’s fastest-growing product....
...Psoriasis drugs were the first to turn dermatology into a high value market, with sales of Stelara by Johnson & Johnson exceeding $10bn a year; four other psoriasis treatments have annual sales above $2.5bn...
...“There is a lot of investor interest and excitement about the development of an options ecosystem.”...
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
...Johnson & Johnson joins the Merck, Bristol Myers Squibb and pharmaceutical lobby Pharmaceutical Research and Manufacturers of America in challenging the new law....
...And he even explores acquiring a pharmaceuticals company to move cocaine around the world disguised as medical exports but that never gets off the ground. But some of his schemes do work....
...The company joins Merck, Bristol Myers Squibb and the lobby group Pharmaceutical Research and Manufacturers of America in challenging the new law....
...“Some of the statistics are difficult to ignore,” agrees Dzmitry Lipski, head of funds research at retail investment platform Interactive Investor....
...The four pharmaceutical companies that part-funded the project — Amgen, AstraZeneca, GSK and Johnson & Johnson, — received nine months’ exclusive access to the data, which will now be made available to approved...
...Regeneron Pharmaceuticals partnered with a consortium of businesses to fund exome sequencing of biobank data....
...Zach Pandl, managing director of research for Grayscale, downplayed the rush out of the firm’s bitcoin ETF, which remains the largest by far....
...Shares in Sanofi fell 19 per cent on Friday after the French pharmaceutical group announced a lower profit outlook and a spinout of its consumer care unit as it seeks to focus on drug research....
...He did not see the development as a conflict of interest, given that the accelerator “operates independently from Goldman Sachs Asset Management”....
...Other drugmakers including Merck, Bristol Myers Squibb, and Johnson & Johnson, as well as the US pharmaceutical lobby group, have already filed lawsuits against the reforms....
...The development may help traditional active fund managers battling against the rising tide of cheap passive index-tracking funds — although they will have to accept lower fees....
...He said Lilly had benefited from its strong research culture and breakthroughs in the two biggest untapped pharmaceutical markets....
...at the ETF Think Tank, the research division of Tidal Financial Group....
...Johnson & Johnson is fighting a bruising battle over tens of thousands of claims its talcum powder caused cancer....
International Edition